Variation in incidence trends of malignant pleural mesothelioma in Europe

Mohammed Ahmed, Antoinette Flannery, Irfan Mujammil, David Breen

Source: Eur Respir J, 51 (2) 1702384; 10.1183/13993003.02384-2017

Journal Issue: February

Disease area: Respiratory infections, Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mohammed Ahmed, Antoinette Flannery, Irfan Mujammil, David Breen. Variation in incidence trends of malignant pleural mesothelioma in Europe. Eur Respir J, 51 (2) 1702384; 10.1183/13993003.02384-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Rise in rates of mesothelioma, asbestosis and of benign asbestos-related pleural disease in NSW over the last 15 years Source: Eur Respir J 2006; 28: Suppl. 50, 694s Year: 2006
Malignant pleural effusion survival prognostication in an Asian population Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019
Management of malignant pleural mesothelioma Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016
Management of malignant pleural mesothelioma Source: ERS Skills Course 2015 Year: 2015
Management of malignant pleural mesothelioma Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013
Management of malignant pleural mesothelioma Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012
Management of malignant pleural mesothelioma Source: School Course 2014 - Medical Thoracoscopy Year: 2014
Survival time in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Rare tumours, risk factors and epidemiology in thoracic oncology Year: 2007
Malignant pleural mesothelioma clinical aspects and survival in 93 cases Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010
Factors effecting malignant pleural mesothelioma incidence in rural part of Eskisehir, Turkey Source: Eur Respir J 2001; 18: Suppl. 33, 534s Year: 2001
Non-malignant pleural disease from asbestos and malignant pleural mesothelioma Source: Eur Respir Monogr 2020; 89: 141-149 Year: 2020
Management of malignant pleural mesothelioma in 2017 Source: ERS Skills course - Medical thoracoscopy Year: 2017
Malignant pleural effusion: different treatments through countries Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019 Year: 2020
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Guideline 2020 Year: 2020
Diagnosis of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004
Mesothelioma in situ with regressive malignant pleural effusion. A year latter Source: Virtual Congress 2021 – CCC Thoracic oncology Year: 2021
Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017